Deaths; cause of death (extensive list), age and sex
| Sex | Age | Causes of death | Periods | Deaths (number) |
|---|---|---|---|---|
| Total male and female | Total | B96 Oth.bacterial agents as the cause .. | 2024 | 0 |
| Total male and female | Total | B97 Viral agents as the cause of dis.. | 2024 | 0 |
| Total male and female | Total | B98 Oth. infectious agents as cause of . | 2024 | 0 |
| Total male and female | Total | C40 M.n. bone and articular cartilage .. | 2024 | 5 |
| Total male and female | Total | C41 M.n. bone and art. cartilage of oth. | 2024 | 106 |
| Total male and female | Total | D16 B.n. of bone and articular cartilage | 2024 | 4 |
| Total male and female | Total | I60 Subarachnoid haemorrhage | 2024 | 355 |
| Total male and female | Total | I61 Intracerebral haemorrhage | 2024 | 1,726 |
| Total male and female | Total | I64 Stroke, not spec. as haemorrhage.. | 2024 | 3,725 |
| Total male and female | Total | I85 Oesophageal varices | 2024 | 17 |
| Total male and female | Total | K21 Gastro-oesophageal reflux disease | 2024 | 9 |
| Total male and female | Total | M88 Paget's disease of bone | 2024 | 4 |
| Total male and female | Total | M94 Other disorders of cartilage | 2024 | 3 |
| Total male and female | Total | O20 Haemorrhage in early pregnancy | 2024 | 0 |
| Total male and female | Total | O46 Antepartum haemorrhage, n.e.c. | 2024 | 0 |
| Total male and female | Total | O72 Postpartum haemorrhage | 2024 | 0 |
| Total male and female | Total | P26 Pulmonary haemorrhage originating.. | 2024 | 1 |
| Total male and female | Total | P51 Umbilical haemorrhage of newborn | 2024 | 0 |
| Total male and female | Total | P54 Other neonatal haemorrhages | 2024 | 2 |
| Total male and female | Total | Q60 Renal agenesis, oth. reduct. defec.. | 2024 | 1 |
| Total male and female | Total | R04 Haemorrhage from respiratory passage | 2024 | 20 |
| Total male and female | Total | R58 Haemorrhage, n.e.c. | 2024 | 38 |
| Total male and female | Total | Y43 Primarily systemic agents | 2024 | 0 |
| Total male and female | Total | Y44 Agents primarily affecting blood .. | 2024 | 0 |
| Total male and female | Total | Y52 Agents primarily aff. cardiovasc.. | 2024 | 0 |
| Total male and female | Total | Y53 Agents primarily aff. gastro/intes.. | 2024 | 0 |
| Total male and female | Total | Y54 Agents primarily aff. water-balance. | 2024 | 0 |
| Total male and female | Total | Y55 Agents primarily acting on smooth .. | 2024 | 0 |
| Total male and female | Total | Y56 Topical agents primarily affecting.. | 2024 | 0 |
| Total male and female | Total | Y63 Failure in dosage during surgical .. | 2024 | 0 |
| Total male and female | 0 year | B96 Oth.bacterial agents as the cause .. | 2024 | 0 |
| Total male and female | 0 year | B97 Viral agents as the cause of dis.. | 2024 | 0 |
| Total male and female | 0 year | B98 Oth. infectious agents as cause of . | 2024 | 0 |
| Total male and female | 0 year | C40 M.n. bone and articular cartilage .. | 2024 | 0 |
| Total male and female | 0 year | C41 M.n. bone and art. cartilage of oth. | 2024 | 0 |
| Total male and female | 0 year | D16 B.n. of bone and articular cartilage | 2024 | 0 |
| Total male and female | 0 year | I60 Subarachnoid haemorrhage | 2024 | 0 |
| Total male and female | 0 year | I61 Intracerebral haemorrhage | 2024 | 0 |
| Total male and female | 0 year | I64 Stroke, not spec. as haemorrhage.. | 2024 | 0 |
| Total male and female | 0 year | I85 Oesophageal varices | 2024 | 0 |
| Total male and female | 0 year | K21 Gastro-oesophageal reflux disease | 2024 | 0 |
| Total male and female | 0 year | M88 Paget's disease of bone | 2024 | 0 |
| Total male and female | 0 year | M94 Other disorders of cartilage | 2024 | 0 |
| Total male and female | 0 year | O20 Haemorrhage in early pregnancy | 2024 | 0 |
| Total male and female | 0 year | O46 Antepartum haemorrhage, n.e.c. | 2024 | 0 |
| Total male and female | 0 year | O72 Postpartum haemorrhage | 2024 | 0 |
| Total male and female | 0 year | P26 Pulmonary haemorrhage originating.. | 2024 | 1 |
| Total male and female | 0 year | P51 Umbilical haemorrhage of newborn | 2024 | 0 |
| Total male and female | 0 year | P54 Other neonatal haemorrhages | 2024 | 2 |
| Total male and female | 0 year | Q60 Renal agenesis, oth. reduct. defec.. | 2024 | 1 |
| Total male and female | 0 year | R04 Haemorrhage from respiratory passage | 2024 | 0 |
| Total male and female | 0 year | R58 Haemorrhage, n.e.c. | 2024 | 0 |
| Total male and female | 0 year | Y43 Primarily systemic agents | 2024 | 0 |
| Total male and female | 0 year | Y44 Agents primarily affecting blood .. | 2024 | 0 |
| Total male and female | 0 year | Y52 Agents primarily aff. cardiovasc.. | 2024 | 0 |
| Total male and female | 0 year | Y53 Agents primarily aff. gastro/intes.. | 2024 | 0 |
| Total male and female | 0 year | Y54 Agents primarily aff. water-balance. | 2024 | 0 |
| Total male and female | 0 year | Y55 Agents primarily acting on smooth .. | 2024 | 0 |
| Total male and female | 0 year | Y56 Topical agents primarily affecting.. | 2024 | 0 |
| Total male and female | 0 year | Y63 Failure in dosage during surgical .. | 2024 | 0 |
| Total male and female | 1 to 4 years | B96 Oth.bacterial agents as the cause .. | 2024 | 0 |
| Total male and female | 1 to 4 years | B97 Viral agents as the cause of dis.. | 2024 | 0 |
| Total male and female | 1 to 4 years | B98 Oth. infectious agents as cause of . | 2024 | 0 |
| Total male and female | 1 to 4 years | C40 M.n. bone and articular cartilage .. | 2024 | 0 |
| Total male and female | 1 to 4 years | C41 M.n. bone and art. cartilage of oth. | 2024 | 1 |
| Total male and female | 1 to 4 years | D16 B.n. of bone and articular cartilage | 2024 | 0 |
| Total male and female | 1 to 4 years | I60 Subarachnoid haemorrhage | 2024 | 0 |
| Total male and female | 1 to 4 years | I61 Intracerebral haemorrhage | 2024 | 0 |
| Total male and female | 1 to 4 years | I64 Stroke, not spec. as haemorrhage.. | 2024 | 0 |
| Total male and female | 1 to 4 years | I85 Oesophageal varices | 2024 | 0 |
| Total male and female | 1 to 4 years | K21 Gastro-oesophageal reflux disease | 2024 | 0 |
| Total male and female | 1 to 4 years | M88 Paget's disease of bone | 2024 | 0 |
| Total male and female | 1 to 4 years | M94 Other disorders of cartilage | 2024 | 0 |
| Total male and female | 1 to 4 years | O20 Haemorrhage in early pregnancy | 2024 | 0 |
| Total male and female | 1 to 4 years | O46 Antepartum haemorrhage, n.e.c. | 2024 | 0 |
| Total male and female | 1 to 4 years | O72 Postpartum haemorrhage | 2024 | 0 |
| Total male and female | 1 to 4 years | P26 Pulmonary haemorrhage originating.. | 2024 | 0 |
| Total male and female | 1 to 4 years | P51 Umbilical haemorrhage of newborn | 2024 | 0 |
| Total male and female | 1 to 4 years | P54 Other neonatal haemorrhages | 2024 | 0 |
| Total male and female | 1 to 4 years | Q60 Renal agenesis, oth. reduct. defec.. | 2024 | 0 |
| Total male and female | 1 to 4 years | R04 Haemorrhage from respiratory passage | 2024 | 0 |
| Total male and female | 1 to 4 years | R58 Haemorrhage, n.e.c. | 2024 | 0 |
| Total male and female | 1 to 4 years | Y43 Primarily systemic agents | 2024 | 0 |
| Total male and female | 1 to 4 years | Y44 Agents primarily affecting blood .. | 2024 | 0 |
| Total male and female | 1 to 4 years | Y52 Agents primarily aff. cardiovasc.. | 2024 | 0 |
| Total male and female | 1 to 4 years | Y53 Agents primarily aff. gastro/intes.. | 2024 | 0 |
| Total male and female | 1 to 4 years | Y54 Agents primarily aff. water-balance. | 2024 | 0 |
| Total male and female | 1 to 4 years | Y55 Agents primarily acting on smooth .. | 2024 | 0 |
| Total male and female | 1 to 4 years | Y56 Topical agents primarily affecting.. | 2024 | 0 |
| Total male and female | 1 to 4 years | Y63 Failure in dosage during surgical .. | 2024 | 0 |
| Total male and female | 5 to 9 years | B96 Oth.bacterial agents as the cause .. | 2024 | 0 |
| Total male and female | 5 to 9 years | B97 Viral agents as the cause of dis.. | 2024 | 0 |
| Total male and female | 5 to 9 years | B98 Oth. infectious agents as cause of . | 2024 | 0 |
| Total male and female | 5 to 9 years | C40 M.n. bone and articular cartilage .. | 2024 | 0 |
| Total male and female | 5 to 9 years | C41 M.n. bone and art. cartilage of oth. | 2024 | 1 |
| Total male and female | 5 to 9 years | D16 B.n. of bone and articular cartilage | 2024 | 0 |
| Total male and female | 5 to 9 years | I60 Subarachnoid haemorrhage | 2024 | 0 |
| Total male and female | 5 to 9 years | I61 Intracerebral haemorrhage | 2024 | 1 |
| Total male and female | 5 to 9 years | I64 Stroke, not spec. as haemorrhage.. | 2024 | 0 |
| Total male and female | 5 to 9 years | I85 Oesophageal varices | 2024 | 0 |
| Source: CBS. | ||||
Table explanation
This table contains the number of deaths in the population of the Netherlands by underlying cause of death. The causes of death are shown according to the extensive list of 'three digit codes', by age and sex.
Since 2013 Statistics Netherlands is using Iris software for automatic coding for cause of death. This improved the international comparison of the data. The change in coding did cause a considerable shift in the statistic. Since 2013 the (yearly) ICD-10 updates are applied.
Data available from: 1996
Status of the figures:
The figures up until 2024 are final.
Changes as of February 12th 2026:
The figures for 2024 have been made final.
When will new figures be published?
The aim is to publish the provisional figures of 2025 in the third quarter of 2026.
Description topics
- Deaths